evenfolioETF Details
Portfolio Building Block ETFs·Health·PBPH · Nasdaq
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
- Price
- $31.35
- —30 Oct 2026
- Assets
- $1B
- Total net assets
- Expense ratio
- 0.13%
- Category 1.00%
- Yield
- —
- Trailing distributions
- 1Y return
- —
- Category 28.8%
- 3Y CAGR
- —
- Category 21.5%
- 5Y CAGR
- —
- Category 4.1%
Loading NAV history…
Portfolio Building Block World Pharma and Biotech Index ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +10.4% | +15.3% | +25.6% | +24.2% | — | — | — | — | +26.6% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +6.8% | +5.4% | +2.6% | +3.8% | — | — | — | — | +15.0% |
Holdings
The 10 largest positions make up 63.4% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 15.31% |
| JNJ | Johnson & Johnson | 10.00% |
| ABBV | AbbVie Inc | 7.25% |
| MRK | Merck & Co Inc | 5.62% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 4.65% |
| AZN.L | AstraZeneca PLC | 4.61% |
| AMGN | Amgen Inc | 4.39% |
| NOVN.SW | Novartis AG Registered Shares | 4.10% |
| GILD | Gilead Sciences Inc | 3.96% |
| PFE | Pfizer Inc | 3.48% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 27.1
- P/B
- 5.3
- P/S
- 4.8
- P/CF
- 17.3
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.8%
- Cash0.2%
ETF details
- Issuer
- Portfolio Building Block ETFs
- Category
- Equity · Health
- Ticker
- PBPH
- Exchange
- Nasdaq
- Inception
- 25 Nov 2025 (0.9 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.13% (category 1.00%)
- Holdings turnover
- 0% (category 51%)
- Distribution yield
- —
- Beta, 3 years
- 0.00
- Total net assets
- $1B
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- PPH · VanEck Pharmaceutical ETFVanEck · $1B · ER 0.36%5Y 11.8%
- RSPH · Invesco S&P 500 Equal Weight Health Care ETFInvesco · $882.1M · ER 0.40%5Y 5.9%
- PJP · Invesco Pharmaceuticals ETFInvesco · $557.2M · ER 0.58%5Y 11.7%
- XPH · State Street SPDR S&P Pharmaceuticals ETFState Street Investment Management · $524M · ER 0.35%5Y 7.5%
- BBH · VanEck Biotech ETFVanEck · $487.7M · ER 0.35%5Y 5.8%
- PBE · Invesco Biotechnology & Genome ETFInvesco · $423.5M · ER 0.59%5Y 6.9%